Mrs Erin Elizabeth Sweeney-bier, MS, CCC-SLP in Adams, NY - Speech-Language Pathologist

Mrs Erin Elizabeth Sweeney-bier, MS, CCC-SLP is a Speech-language Pathologist based in Adams, New York. Mrs Erin Elizabeth Sweeney-bier is licensed to practice in New York (license number 017724) and her current practice location is 11060 Us Route 11, Adams, New York. She can be reached at her office (for appointments etc.) via phone at (315) 583-5283.

NPI number for Mrs Erin Elizabeth Sweeney-bier is 1669753703 and her current mailing address is Po Box 10, Adams, New York. She does not participate in medicare program and thus does not accept medicare assignments. Her NPI Number is 1669753703.

Contact Information

	Mrs Erin Elizabeth Sweeney-bier, MS, CCC-SLP
	11060 Us Route 11, Adams, NY 13605-2110
	(315) 583-5283
	Not Available

Healthcare Provider's Profile

Full Name	Mrs Erin Elizabeth Sweeney-bier
Gender	Female
Speciality	Speech-language Pathologist
Location	11060 Us Route 11, Adams, New York
Accepts Medicare Assignments	Does not participate in Medicare Program. She may not accept medicare assignment.

NPI Data:

NPI Number: 1669753703
Provider Enumeration Date: 09/02/2011
Last Update Date: 07/22/2014

Medical Identifiers

Medical identifiers for Mrs Erin Elizabeth Sweeney-bier such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1669753703	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
235Z00000X	Speech-language Pathologist	017724 (New York)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Mrs Erin Elizabeth Sweeney-bier is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Mrs Erin Elizabeth Sweeney-bier, MS, CCC-SLP Po Box 10, Adams, NY 13605-0010 Ph: (315) 583-5283	Mrs Erin Elizabeth Sweeney-bier, MS, CCC-SLP 11060 Us Route 11, Adams, NY 13605-2110 Ph: (315) 583-5283

News Archive

Researchers investigate antimicrobial activity of Aganocide compounds against H1N1

Fears over the influenza A virus (H1N1; sometimes referred to as swine flu) have motivated researchers to investigate the antimicrobial activity of the Aganocide compounds against viruses. In a study presented at this year's Interscience Conference on Antimicrobial Agents and Chemotherapy, a team led by Professor Markus Nagl, MD of Medical University of Innsbruck and including D. Debabov, PhD and K. Hybiske, PhD of NovaBay Pharmaceuticals evaluated the in vitro virucidal activity of three compounds: N-chlorotaurine, a compound produced by human phagocytes; and two NCT analogs, NVC-612 and NVC-422.

Inter-arm blood pressure differences in children could lead to wrong diagnosis

Blood pressure measurements in children and adolescents should be taken from both arms after new research showed substantial differences could be seen depending on which arm was used.

Insect virus holds key to safer stem cell therapy: Singapore scientists

The future of regenerative medicine lies in harnessing the potential of the human body to renew and repair itself. Now, scientists at the Institute of Bioengineering and Nanotechnology (IBN), the world's first bioengineering and nanotechnology research institute, have developed a new genetic engineering technique that promises safer stem cell therapy for cancer patients. Using an insect virus, the team of researchers successfully inserted a therapeutic gene into a safe site in the DNA of human embryonic stem cells without compromising the functionality of the engineered cells.

Scientists identify unusual mutations in endometriosis using gene sequencing tools

Using gene sequencing tools, scientists from Johns Hopkins Medicine and the University of British Columbia have found a set of genetic mutations in samples from 24 women with benign endometriosis, a painful disorder marked by the growth of uterine tissue outside of the womb.

Global CO2 emissions have increased by 58% since 1990

Carbon dioxide emission reductions required to limit global warming to 2-C are becoming a receding goal based on new figures reported today in the latest Global Carbon Project (GCP) calculations published today in the advanced online edition of Nature Climate Change. "A shift to a 2-C pathway requires an immediate, large, and sustained global mitigation effort" says GCP executive-director and CSIRO co-author of the paper, Dr Pep Canadell.

Mrs Erin Elizabeth Sweeney-bier, MS, CCC-SLP - Speech-Language Pathologist in Adams, NY